| Product Code: ETC8539119 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of gamma-aminobutyric acid (GABA) receptor agonists in the Netherlands have shown remarkable growth in 2024, with a staggering growth rate of 265.92% compared to the previous year. The top exporting countries to the Netherlands in 2024 include India, Metropolitan France, Germany, China, and Hong Kong. The market concentration, as measured by the HHI, has significantly increased from high to very high in 2024, indicating a more consolidated market landscape. With a strong compound annual growth rate (CAGR) of 8.39% from 2020 to 2024, the Netherlands remains a key market for GABA receptor agonist imports.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Industry Life Cycle |
3.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Porter's Five Forces |
3.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders such as anxiety and epilepsy leading to higher demand for GABA receptor agonists. |
4.2.2 Growing awareness about the benefits of GABA receptor agonists in managing stress and promoting relaxation. |
4.2.3 Rising research and development activities focused on developing novel GABA receptor agonists with improved efficacy. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new GABA receptor agonist drugs. |
4.3.2 Side effects and safety concerns associated with long-term use of GABA receptor agonists. |
4.3.3 Competition from alternative therapies and medications for managing neurological disorders. |
5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends |
6 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Types |
6.1 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Spasticity, 2021- 2031F |
6.1.6 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.7 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Zolpidem, 2021- 2031F |
6.2.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Topiramate, 2021- 2031F |
6.2.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.2.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Therapeutics |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Bamaluzole, 2021- 2031F |
6.3.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Phenibut, 2021- 2031F |
6.3.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Gaboxadol, 2021- 2031F |
6.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Intrathecal, 2021- 2031F |
6.4.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Import-Export Trade Statistics |
7.1 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Export to Major Countries |
7.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Imports from Major Countries |
8 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Key Performance Indicators |
8.1 Number of clinical trials evaluating the efficacy of new GABA receptor agonists. |
8.2 Patient adherence rates to GABA receptor agonist treatments. |
8.3 Prescription rates of GABA receptor agonists by healthcare providers. |
8.4 Patient-reported outcomes related to the effectiveness of GABA receptor agonists in managing symptoms. |
8.5 Research funding allocated to studying GABA receptor agonists and their potential applications. |
9 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Opportunity Assessment |
9.1 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.4 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Competitive Landscape |
10.1 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |